ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,602Medicare Part D Prescriptions Filled, Including Refills

Rank: 949 out of 3647

$487K Total Retail Price of All Prescriptions

Rank: 1147 out of 3647

201 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 201 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,258 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
PRAVASTATIN SODIUM 810 698 1 16
METOLAZONE 593 502 10 2 251
LISINOPRIL 427 350 3 4
OMEPRAZOLE 367 344 4 3
AMLODIPINE BESYLATE 279 249 5 2
LOSARTAN POTASSIUM 217 196 6 11
FLUTICASONE PROPIONATE 213 178 7 32
RANITIDINE HCL 210 174 8 29
METFORMIN HCL 190 186 9 6
DIOVAN 178 140 10 40
METFORMIN HCL ER 171 129 11 92
LEVOTHYROXINE SODIUM 171 143 11 5
MELOXICAM 147 134 13 33
LANTUS 147 123 13 59
ATENOLOL 127 112 15 10
NEXIUM 122 83 16 44
NIFEDIPINE ER 120 107 17 67
FUROSEMIDE 110 100 18 8
MECLIZINE HCL 109 94 19 85
POTASSIUM CHLORIDE 100 87 20 24
METOPROLOL TARTRATE 98 94 21 7
NYSTATIN-TRIAMCINOLONE 92 74 22 201
METOPROLOL SUCCINATE 92 76 22 18
CLOPIDOGREL 90 81 24 26
GLIPIZIDE 86 78 25 41
NASONEX 85 80 26 220
CILOSTAZOL 78 78 27 168
CRESTOR 76 61 28 19
PLAVIX 75 69 29 39
FLOVENT HFA 73 73 30 345
CARVEDILOL 72 68 31 20
FOLIC ACID 71 66 32 95
INSULIN SYRINGE 69 48 33 76
GLYBURIDE 67 48 R 34 54
ACTOS 66 49 35 148
BUSPIRONE HCL 61 38 36 162
CLONIDINE HCL 61 61 36 46
DONEPEZIL HCL 58 57 38 30
FLUCONAZOLE 57 47 39 226
ADVAIR DISKUS 57 54 39 52
TERAZOSIN HCL 56 50 41 103
ALPRAZOLAM 55 55 42 31
LANSOPRAZOLE 53 33 43 116
ESCITALOPRAM OXALATE 52 31 44 65
GLIPIZIDE ER 51 44 45 112
SINGULAIR 51 41 45 90
PAROXETINE HCL 51 51 45 60
FOSINOPRIL SODIUM 50 45 48 241
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.